Didn't Q3 2021 end on February 28, 2021? CytoDyn is not on a calendar year fiscal basis. The fiscal year ends May 31, 2021, right? Unfortunately, with such a poorly written PR you have to parse out the facts. So, isn't the "request for rolling review" past tense? And, then "remaining portions later in the year is on schedule" makes more sense, meaning as stated also in the PR that "CytoDyn expects to refile its BLA in the first half of the calendar year 2021 or shortly thereafter." Am I too optimistic or does what I say here make sense?